Dexchlorpheniramine Maleate

Spécifications

2438-32-6Numéro CAS

219-450-6Numéro CE

(Z)-but-2-enedioic acid;(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amineNom IUPAC

C20H23ClN2O4Formule chimique

390.9 g/molMasse molaire

Dexchlorpheniramine maleate; 2438-32-6; d-Chlorpheniramine maleate; Dextrochlorpheniramine maleate; Mylaramine; Chlorpheniramine d-form maleate; B10YD955QW; Chlorpheniramine maleate, (s)-; S-(+)-Chlorpheniramine maleate; NSC-759156; Dexchlorpheniramine maleate (USP); Dexchlorpheniramine maleate [USP]; DTXSID001017216; (2Z)-but-2-enedioic acid; [(3S)-3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine; (gamma-(4-Chlorophenyl)-pyridine-2-propyl)(dimethyl)ammonium hydrogen (Z)-maleate; 2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1); (2Z)-but-2-enedioic acid; ((3S)-3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl)dimethylamine; POLMON; RYCLORA; RefChem:54963; DTXCID801475404; (+)-2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate(1:1); (3S)-3-(4-Chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropylamine monomaleate; (gamma-(4-Chlorophenyl)-pyridine-2-propyl)(dimethyl)ammonium hydrogen(Z)-maleate; 219-450-6; Polaramine; Dexchlorpheniramine (maleate); Dexchloropheniramine maleate; (S)-Chlorpheniramine Maleate Salt; MFCD00079046; DeXchlorpheniramine Maleate, USP; (S)-Chlorpheniramine maleate; S-(+)-Chlorpheniramine maleate salt; C20H23ClN2O4; (Z)-but-2-enedioic acid;(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; CHEBI:4465; SR-01000075763; UNII-B10YD955QW; polar amine; Rescon JR; Rescon MX; Mylaramine (TN); Polaramine (TN); Brompheniramine Maleate Imp. B (EP); Brompheniramine Imp. B (EP); Dexchlorpheniramine Maleate; Brompheniramine Maleate Imp. B (EP) as Maleate; Brompheniramine Maleate Impurity B as Maleate; Brompheniramine Impurity B as Maleate; EINECS 219-450-6; Dexchlorpheniraminmaleat; MLS001401384; SCHEMBL119500; Dexchlorpheniramine maleate CRS; orb1225541; orb1310295; CHEMBL1200927; HY-B1062R; HMS2052E15; HMS2233I15; HMS3260F10; d-Chlorpheniramine maleate (JP18); HY-B1062; Tox21_500264; EBC-12136; EX-A10890; (+)-2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1); AKOS015962825; CCG-101121; CS-4618; DB09555; FC20405; LP00264; NC00371; NSC 759156; D-CHLORPHENIRAMINE MALEATE [JAN]; Dexchlorpheniramine (maleate) (Standard); NCGC00093722-01; NCGC00093722-02; NCGC00093722-03; NCGC00260949-01; 2-Pyridinepropanamine, .gamma.-(4-chlorophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1); AC-19009; AS-17464; DA-72706; SMR000471617; DEXCHLORPHENIRAMINE MALEATE [VANDF]; DEXCHLORPHENIRAMINE MALEATE [USP-RS]; DEXCHLORPHENIRAMINE MALEATE [WHO-DD]; CHLORPHENIRAMINE D-FORM MALEATE [MI]; EU-0100264; T0785; C 4915; C07783; D00668; G12280; DEXCHLORPHENIRAMINE MALEATE [EP IMPURITY]; DEXCHLORPHENIRAMINE MALEATE [ORANGE BOOK]; EN300-1273237; DEXCHLORPHENIRAMINE MALEATE [EP MONOGRAPH]; DEXCHLORPHENIRAMINE MALEATE [USP MONOGRAPH]; SR-01000075763-1; SR-01000075763-4; Q27106393; 2-[p-Chloro-a-[2-(dimethylamino)ethyl]benzyl ]pyridine maleate; (gammaS)-gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine maleate; (s)-?-(4-chlorophenyl)-n,n-dimethyl-2-pyridinepropanamine maleate salt; Dexchlorpheniramine maleate, European Pharmacopoeia (EP) Reference Standard; (+)-2-(P-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)BENZYL)PYRIDINE MALEATE (1:1); (3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid; (3S)-3-(4-Chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (Z)-butenedioate; (gamma-S)-gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine (2Z)-2-butenedioate; Dexchlorpheniramine maleate, United States Pharmacopeia (USP) Reference Standard; Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (+)-; (2Z)-But-2-enedioic acid--(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (1/1)Synonymes